R&D expertise
International PharmaScience Center makes up the development organisation of Ferring Pharmaceuticals worldwide. This means that our team of approximately 250 scientists is driving Ferring’s R&D strategy in collaboration with colleagues at our corporate headquarters in Switzerland and our research centre in the United States.
We want to develop new medicine within our existing therapeutic areas: urology, reproductive health, gastroenterology and endocrinology. And we believe that this goal deserves a constant and competitive investment in technologies, laboratories and training. Research is the foundation of our company, and we want to give our employees access to the best facilities within their field. This is our way of stimulating their scientific curiosity. It is also our way of securing our future as a company through a flow of innovative products.
Ferring has led innovation in the field of naturally-occurring human peptides for the past 50 years. Today, Ferring has an exciting product portfolio that includes several major projects for innovative treatment within our existing therapeutic areas. We believe that we are still in the process of realising the full potential of our expertise within naturally-occurring human peptides, and a continued commitment to research within this areas will be the primary way to secure our future success.